Iovance Biotherapeutics, Inc. IOVA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s other non-current assets?
- Iovance Biotherapeutics, Inc. (IOVA) reported other non-current assets of $8.29M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s other non-current assets changed year-over-year?
- Iovance Biotherapeutics, Inc.'s other non-current assets increased by 1846.2% year-over-year, from $426K to $8.29M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s other non-current assets has grown at a -8.8% compound annual growth rate (CAGR), from $12.92M to $8.17M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.